144 related articles for article (PubMed ID: 23570469)
1. Pharmacogenomics of bipolar disorder.
Severino G; Squassina A; Costa M; Pisanu C; Calza S; Alda M; Del Zompo M; Manchia M
Pharmacogenomics; 2013 Apr; 14(6):655-74. PubMed ID: 23570469
[TBL] [Abstract][Full Text] [Related]
2. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
Pisanu C; Heilbronner U; Squassina A
Mol Diagn Ther; 2018 Aug; 22(4):409-420. PubMed ID: 29790107
[TBL] [Abstract][Full Text] [Related]
3. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
[TBL] [Abstract][Full Text] [Related]
4. Lithium Pharmacogenetics: Where Do We Stand?
Pisanu C; Melis C; Squassina A
Drug Dev Res; 2016 Nov; 77(7):368-373. PubMed ID: 27633500
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics and bipolar disorder.
Mamdani F; Groisman IJ; Alda M; Turecki G
Pharmacogenomics J; 2004; 4(3):161-70. PubMed ID: 15079146
[TBL] [Abstract][Full Text] [Related]
6. The early manifestations of bipolar disorder: a longitudinal prospective study of the offspring of bipolar parents.
Duffy A; Alda M; Crawford L; Milin R; Grof P
Bipolar Disord; 2007 Dec; 9(8):828-38. PubMed ID: 18076532
[TBL] [Abstract][Full Text] [Related]
7. Genetics of Lithium Response in Bipolar Disorder.
Papiol S; Schulze TG; Alda M
Pharmacopsychiatry; 2018 Sep; 51(5):206-211. PubMed ID: 29579760
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and mood stabilization in bipolar disorder.
Ruzickova M; Turecki G; Alda M
Am J Med Genet C Semin Med Genet; 2003 Nov; 123C(1):18-25. PubMed ID: 14601033
[TBL] [Abstract][Full Text] [Related]
9. Family-based exome-sequencing approach identifies rare susceptibility variants for lithium-responsive bipolar disorder.
Cruceanu C; Ambalavanan A; Spiegelman D; Gauthier J; Lafrenière RG; Dion PA; Alda M; Turecki G; Rouleau GA
Genome; 2013 Oct; 56(10):634-40. PubMed ID: 24237345
[TBL] [Abstract][Full Text] [Related]
10. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.
Breen MS; White CH; Shekhtman T; Lin K; Looney D; Woelk CH; Kelsoe JR
Pharmacogenomics J; 2016 Oct; 16(5):446-53. PubMed ID: 27401222
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms.
Serretti A; Drago A
Neuropsychobiology; 2010; 62(1):61-71. PubMed ID: 20453536
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic aspects of bipolar disorder: An update.
Budde M; Degner D; Brockmöller J; Schulze TG
Eur Neuropsychopharmacol; 2017 Jun; 27(6):599-609. PubMed ID: 28342679
[TBL] [Abstract][Full Text] [Related]
13. Lithium specificity in bipolar illness: a classic agent for the classic disorder.
Gershon S; Chengappa KN; Malhi GS
Bipolar Disord; 2009 Jun; 11 Suppl 2():34-44. PubMed ID: 19538684
[TBL] [Abstract][Full Text] [Related]
14. [Genetics of bipolar disorder].
Budde M; Forstner AJ; Adorjan K; Schaupp SK; Nöthen MM; Schulze TG
Nervenarzt; 2017 Jul; 88(7):755-759. PubMed ID: 28474173
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder.
Sussulini A; Dihazi H; Banzato CE; Arruda MA; Stühmer W; Ehrenreich H; Jahn O; Kratzin HD
Proteomics; 2011 Jan; 11(2):261-9. PubMed ID: 21204253
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic aspects of bipolar disorder.
Alda M
Pharmacogenomics; 2003 Jan; 4(1):35-40. PubMed ID: 12517284
[TBL] [Abstract][Full Text] [Related]
17. Towards the clinical implementation of pharmacogenetics in bipolar disorder.
Salloum NC; McCarthy MJ; Leckband SG; Kelsoe JR
BMC Med; 2014 May; 12():90. PubMed ID: 24885933
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
Licht RW; Vestergaard P; Brodersen A
Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment in bipolar disorder: an overview.
Manove E; Levy B
Postgrad Med; 2010 Jul; 122(4):7-16. PubMed ID: 20675966
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of lithium response in bipolar disorder.
McCarthy MJ; Leckband SG; Kelsoe JR
Pharmacogenomics; 2010 Oct; 11(10):1439-65. PubMed ID: 21047205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
